BRCA1 and neoplasm: While studies have not examined the prognostic ramifications of tumor-cell PDGF/PDGFRβ expression, our results here using mouse and human tumors indicate a high likelihood that tumor cell PDGFRβ staining might provide prognostic information in BRCA1/INK4-RB-deficient tumors.